Just came across this article from the Independent yesterday.
https://www.independent.co.uk/news/science/cancer-intermittent-fasting-health-risk-b2290767.html
The actual research itself, as per the reporting in the article, does not look at cancer at all, but the author of the piece really tries their best to suggest a crazy negative impact of the practice.
Research out of the same hospital shows reduced inflammation and therefore positive effects on the heart with fasting. Because there is a migration of monocytes from the blood in the fasted mice, the reasoning is there is a lower immune response while fasting. At least that’s the claim I see in it.
Also the conflict of interest statement includes “Alnylam, Bioteonik, CSL Behring, GlycoMimetiks, GSK, Medtronic, Novartis, and Pfizer as well as consulting fees from Lilly, Biogen, Gimv, IMF Therapeutics, Molecular Imaging, Siligon, and Verseau Therapeutics. FKS received funds or material research support from Novartis, Partner Therapeutics, Pfizer, and Verseau Therapeutics.”